Healthcare Stocks

Renalytix Announces About $20.3 Mln Private Placement

  • February 08, 2023 07:45 AM GMT | Reuters
 Renalytix Announces About $20.3 Mln Private Placement

Feb 8 (Reuters) - Renalytix PLC: * RENALYTIX PLC - RENALYTIX ANNOUNCES A C.$20.3M PRIVATE PLACEMENT Source text for Eikon: Further company coverage:

Read More...
Inspiration Health Says EBITDA In Second Half Will Be Below That Of First Half

Inspiration Health Says EBITDA In Second Half Will Be Below That Of First Half

  • November 28, 2022 07:52 AM GMT | Reuters

Nov 28 (Reuters) - Inspiration Healthcare Group PLC : * INSPIRATION HEALTH - UPDATE ON TRADING * INSPIRATION HEALTHCARE GROUP PLC - KNOCK-ON IMPACT ON EBITDA IN SECOND HALF MEANS THAT IT WILL BE BELOW

Read More...
Inspiration Health Says Second Half Ebitda Will Be Below First Half

Inspiration Health Says Second Half Ebitda Will Be Below First Half

  • November 28, 2022 07:51 AM GMT | Reuters

Nov 28 (Reuters) - Inspiration Healthcare Group PLC : * UPDATE ON TRADING * KNOCK-ON IMPACT ON EBITDA IN SECOND HALF MEANS THAT IT WILL BE BELOW THAT OF FIRST HALF Source text for Eikon: Further

Read More...
MEDIA-Blood clot drug Apixaban totally ineffective as post-Covid treatment, UK research finds - FT

MEDIA-Blood clot drug Apixaban totally ineffective as post-Covid treatment, UK research finds - FT

  • November 27, 2022 01:09 PM GMT | Reuters

-- Source link: https://on.ft.com/3U5tlbm -- Note: Reuters has not verified this story and does not vouch for its accuracy

Read More...
GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate For Regulatory Review

GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate For Regulatory Review

  • November 26, 2022 12:13 AM GMT | Reuters

Nov 25 (Reuters) - GSK plc: * GSK CANADA SUBMITS RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE FOR REGULATORY REVIEW Source text for Eikon: Further company coverage:

Read More...
Researchers test mRNA technology for universal flu vaccine

Researchers test mRNA technology for universal flu vaccine

  • November 25, 2022 11:00 PM GMT | Reuters

By Nancy Lapid (Reuters) - An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway

Read More...
Airbus may delay some 2023 jet deliveries -sources

Airbus may delay some 2023 jet deliveries -sources

  • November 25, 2022 06:50 PM GMT | Reuters

(Adds context, details) By Tim Hepher PARIS, Nov 25 (Reuters) - Airbus is preparing the ground for further delays to planned delivery dates of some medium-haul aircraft in 2023 even as it races to

Read More...
UK open to talks over nurses strike, but stands by previous pay offer - minister

UK open to talks over nurses strike, but stands by previous pay offer - minister

  • November 25, 2022 08:05 AM GMT | Reuters

LONDON (Reuters) - British Health Secretary Steve Barclay said on Friday he was open to talks with nurses union RCN but highlighted the merits of a pay rise that was set out by the government in July.

Read More...
British nurses to stage first strikes on Dec. 15, 20

British nurses to stage first strikes on Dec. 15, 20

  • November 25, 2022 02:23 AM GMT | Reuters

LONDON (Reuters) - Thousands of British nurses will go on strike on Dec. 15 and 20 for more pay, their union said on Friday, adding to a winter of industrial action and putting further pressure on the

Read More...
Omega Diagnostics Expects FY Sales To Be Lower Than Previously Anticipated

Omega Diagnostics Expects FY Sales To Be Lower Than Previously Anticipated

  • November 24, 2022 07:29 AM GMT | Reuters

Nov 24 (Reuters) - Omega Diagnostics Group PLC: * OMEGA DIAGNOSTICS GROUP PLC H1 ADJUSTED EBITDA LOSS 200,000 STG * OMEGA DIAGNOSTICS GROUP PLC H1 REVENUE FELL 18 PERCENT TO 3.4 MILLION STG * OUR FULL

Read More...
Abingdon Health Says FY Revenue Down 76%

Abingdon Health Says FY Revenue Down 76%

  • November 24, 2022 07:23 AM GMT | Reuters

Nov 24 (Reuters) - Abingdon Health PLC: * FY ADJUSTED EBITDA LOSS 10.0 MILLION STG * FY REVENUE FELL 76 PERCENT TO 2.8 MILLION STG Source text for Eikon: Further company coverage:

Read More...